title: Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior.
abstract: gamma-Aminobutyric acid type A receptors (GABA(A)-Rs) mediate the bulk of rapid inhibitory synaptic transmission in the central nervous system. The beta3 subunit is an essential component of the GABA(A)-R in many brain regions, especially during development, and is implicated in several pathophysiologic processes. We examined mice harboring a beta3 gene inactivated by gene targeting. GABA(A)-R density is approximately halved in brain of beta3-deficient mice, and GABA(A)-R function is severely impaired. Most beta3-deficient mice die as neonates; some neonatal mortality, but not all, is accompanied by cleft palate. beta3-deficient mice that survive are runted until weaning but achieve normal body size by adulthood, although with reduced life span. These mice are fertile but mothers fail to nurture offspring. Brain morphology is grossly normal, but a number of behaviors are abnormal, consistent with the widespread location of the beta3 subunit. The mice are very hyperactive and hyperresponsive to human contact and other sensory stimuli, and often run continuously in tight circles. When held by the tail, they hold all paws in like a ball, which is frequently a sign of neurological impairment. They have difficulty swimming, walking on grids, and fall off platforms and rotarods, although they do not have a jerky gait. beta3-deficient mice display frequent myoclonus and occasional epileptic seizures, documented by electroencephalographic recording. Hyperactivity, lack of coordination, and seizures are consistent with reduced presynaptic inhibition in spinal cord and impaired inhibition in higher cortical centers and/or pleiotropic developmental defects.
authors.affiliation: Department of Anesthesiology/Critical Care Medicine, University of Pittsburgh School of Medicine, PA 15261, USA. Homanics@smtp.anes.upmc.edu
authors.forename: G E
authors.initials: GE
authors.lastname: Homanics
authors.forename: T M
authors.initials: TM
authors.lastname: DeLorey
authors.forename: L L
authors.initials: LL
authors.lastname: Firestone
authors.forename: J J
authors.initials: JJ
authors.lastname: Quinlan
authors.forename: A
authors.initials: A
authors.lastname: Handforth
authors.forename: N L
authors.initials: NL
authors.lastname: Harrison
authors.forename: M D
authors.initials: MD
authors.lastname: Krasowski
authors.forename: C E
authors.initials: CE
authors.lastname: Rick
authors.forename: E R
authors.initials: ER
authors.lastname: Korpi
authors.forename: R
authors.initials: R
authors.lastname: Mäkelä
authors.forename: M H
authors.initials: MH
authors.lastname: Brilliant
authors.forename: N
authors.initials: N
authors.lastname: Hagiwara
authors.forename: C
authors.initials: C
authors.lastname: Ferguson
authors.forename: K
authors.initials: K
authors.lastname: Snyder
authors.forename: R W
authors.initials: RW
authors.lastname: Olsen
mesh_terms: D017204:Angelman Syndrome / Q000235:genetics*; D000818:Animals; D001522:Behavior, Animal / Q000502:physiology; D002972:Cleft Palate / Q000235:genetics* / Q000503:physiopathology; D004827:Epilepsy / Q000235:genetics* / Q000503:physiopathology; D018390:Gene Targeting; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D018079:Receptors, GABA / Q000502:physiology*
chemical_list: D018079:Receptors, GABA